Literature DB >> 19836484

Surgical management of MEN-1 and -2: state of the art.

Göran Akerström1, Peter Stålberg.   

Abstract

Multiple endocrine neoplasia syndrome type 1 (MEN-1) consists of endocrine tumors of the parathyroid, the endocrine pancreas-duodenum, and the pituitary. Surveillance and screening for the endocrinopathies is recommended in gene carriers. Surgery for MEN-1-related hyperparathyroidism is generally performed as radical subtotal parathyroidectomy, because less surgery is likely to result in persistent or recurrent disease. Multiple endocrine neoplasia syndrome type 2 (MEN-2) consists of medullary thyroid carcinoma, pheochromocytoma, and hyperparathyroidism. Prophylactic thyroidectomy based on DNA testing in the MEN-2 syndrome is considered one of the greater achievements in cancer treatment, because it may be performed before thyroid carcinoma development and provides cure for the patient.

Entities:  

Mesh:

Year:  2009        PMID: 19836484     DOI: 10.1016/j.suc.2009.06.016

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  11 in total

1.  Preoperative localizing studies for initial parathyroidectomy in MEN1 syndrome: is there any benefit?

Authors:  Naris Nilubol; Lee Weinstein; William F Simonds; Robert T Jensen; Giao Q Phan; Marybeth S Hughes; Steven K Libutti; Stephen Marx; Electron Kebebew
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

Review 2.  Translational research in endocrine surgery.

Authors:  Scott K Sherman; James R Howe
Journal:  Surg Oncol Clin N Am       Date:  2013-07-26       Impact factor: 3.495

3.  Lymph nodes metastasis and recurrences justify an aggressive treatment of gastrinoma.

Authors:  Francesco Giovinazzo; Giovanni Butturini; Daniela Monsellato; Giuseppe Malleo; Giovanni Marchegiani; Claudio Bassi
Journal:  Updates Surg       Date:  2013-02-16

4.  Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy.

Authors:  Naris Nilubol; Allison B Weisbrod; Lee S Weinstein; William F Simonds; Robert T Jensen; Giao Q Phan; Marybeth S Hughes; Steven K Libutti; Stephen Marx; Electron Kebebew
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

5.  Non-invasive prenatal diagnosis of multiple endocrine neoplasia type 2A using COLD-PCR combined with HRM genotyping analysis from maternal serum.

Authors:  Hada C Macher; Maria A Martinez-Broca; Amalia Rubio-Calvo; Cristina Leon-Garcia; Manuel Conde-Sanchez; Alzenira Costa; Elena Navarro; Juan M Guerrero
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

6.  Multiple endocrine neoplasia 2a presenting with pheochromocytoma and pituitary macroadenoma.

Authors:  Jonathan E Heinlen; David D Buethe; Daniel J Culkin; Gennady Slobodov
Journal:  ISRN Oncol       Date:  2011-04-18

7.  Diagnosis and surgical treatment of multiple endocrine neoplasia type 2A.

Authors:  Kun-Long Tang; Yi Lin; Li-Ming Li
Journal:  World J Surg Oncol       Date:  2014-01-09       Impact factor: 2.754

8.  Multiple endocrine neoplasia type 1- presenting multiple lipomas and hypoglycemia onset.

Authors:  Jianzhong Li; Lixian Zeng; Yidong Yang; Yashi Zhan; Jin Tao; Bin Wu
Journal:  Am J Case Rep       Date:  2012-09-10

Review 9.  Surgical management of pancreatico-duodenal tumors in multiple endocrine neoplasia syndrome type 1.

Authors:  Göran Akerström; Peter Stålberg; Per Hellman
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

Review 10.  A differential diagnosis of inherited endocrine tumors and their tumor counterparts.

Authors:  Sergio P A Toledo; Delmar M Lourenço; Rodrigo A Toledo
Journal:  Clinics (Sao Paulo)       Date:  2013-07       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.